Skip to main content

Articles

Page 37 of 45

  1. Epigenetic control using histone deacetylase (HDAC) inhibitors is a promising therapy for lymphomas. Insights into the anti-proliferative effects of HDAC inhibitors on diffuse large B-cell lymphoma (DLBCL) and...

    Authors: Ying Cai, Wenli Cui, Weixiang Chen, Ping Wei, Yayun Chi, Ping Zhang, Rui Bi and Xiaoyan Zhou

    Citation: Cancer Cell International 2013 13:57

    Content type: Primary research

    Published on:

  2. Nowadays it remains a controversial issue whether a correlation exists between the apoptosis rate of tumor tissue and the prognosis of the patients. We aimed to explore the prognostic significance of apoptosis...

    Authors: Xing Wu, Biao Cheng, Zheng-dong Cai and Lie-ming Lou

    Citation: Cancer Cell International 2013 13:56

    Content type: Primary research

    Published on:

  3. For their various bioactivities, biomaterials derived from marine algae are important ingredients in many products, such as cosmetics and drugs for treating cancer and other diseases. This mini-review comprehe...

    Authors: Jin-Ching Lee, Ming-Feng Hou, Hurng-Wern Huang, Fang-Rong Chang, Chi-Chen Yeh, Jen-Yang Tang and Hsueh-Wei Chang

    Citation: Cancer Cell International 2013 13:55

    Content type: Review

    Published on:

  4. Apigenin (4’,5,7-trihydroxyflavone) was recently shown effective in inhibiting several cancers. The aim of this study was to investigate the effect and mechanism of apigenin in the human bladder cancer cell li...

    Authors: Yi Zhu, Yeqing Mao, Hong Chen, Yiwei Lin, Zhenghui Hu, Jian Wu, Xin Xu, Xianglai Xu, Jie Qin and Liping Xie

    Citation: Cancer Cell International 2013 13:54

    Content type: Primary research

    Published on:

  5. The pro-apoptotic Bcl-2 protein BAD initiated apoptosis in human cells and has been identified as a prognostic marker in non-small cell lung cancer (NSCLC). In this study, we aimed to explore the functions of ...

    Authors: Li Jiang, Man Luo, Dan Liu, Bojiang Chen, Wen Zhang, Lin Mai, Jing Zeng, Na Huang, Yi Huang, Xianming Mo and Weimin Li

    Citation: Cancer Cell International 2013 13:53

    Content type: Primary research

    Published on:

  6. Doxorubicin (DOX), an anthracycline antibiotic is one of the most effective anticancer drug used in the treatment of variety of cancers .Its use is limited by its cardiotoxicity. The present study was designed...

    Authors: Abdel-Moneim M Osman, Sameer E Al-Harthi, Ohoud M AlArabi, Mohamed F Elshal, Wafaa S Ramadan, Mohamed N Alaama, Huda M Al-Kreathy, Zoheir A Damanhouri and Osman H Osman

    Citation: Cancer Cell International 2013 13:52

    Content type: Primary research

    Published on:

  7. MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human can...

    Authors: Yuan Shao, Yiping Qu, Siwen Dang, Bowen Yao and Meiju Ji

    Citation: Cancer Cell International 2013 13:51

    Content type: Primary research

    Published on:

  8. Celastrol, a plant triterpene, is known to play important role in inhibiting proliferation and inducing apoptosis of gastric cancer cells. In the present study, the mechanism of celastrol on gastric cancer cel...

    Authors: Min Sha, Jun Ye, Li-xin Zhang, Zheng-yun Luan and Ya-bao Chen

    Citation: Cancer Cell International 2013 13:50

    Content type: Primary research

    Published on:

  9. Epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase (RTK) family. Epidermal growth factor induces its dimerization and stimulates phosphorylation of intracellular tyrosine resid...

    Authors: Mi Jeong Jo, Seong Ja Bae, Byeng Wha Son, Chi Yeon Kim and Gun Do Kim

    Citation: Cancer Cell International 2013 13:49

    Content type: Primary research

    Published on:

  10. Up-regulation of heat shock protein 70 (HSP70) could be elicited primarily by heat in former studies, and this was proved to be associated with cancer progression. Burkitt's lymphoma is one of highly aggressiv...

    Authors: Xiaosheng Fang, Yujie Jiang, Lili Feng, Haiping Chen, Changqing Zhen, Mei Ding and Xin Wang

    Citation: Cancer Cell International 2013 13:48

    Content type: Primary research

    Published on:

  11. Cranial radiation therapy has been used for the treatment of primary and metastatic brain tumors. A prominent feature of brain injury induced by the radiation therapy is hippocampal dysfunction, characterized ...

    Authors: Ai-Min Sun, Chuan-Gang Li, Yong-Qing Han, Que-Ling Liu, Qiong Xia and Ya-Wei Yuan

    Citation: Cancer Cell International 2013 13:47

    Content type: Primary research

    Published on:

  12. The multidrug resistance (MDR) 1 gene encodes a 170-kDa membrane transporter called P-glycoprotein, which plays an important role in protecting cells against lipophilic xenobiotics by the way of an ATP-dependent ...

    Authors: Ling-Hui Wang, Yan-Bin Song, Wen-Ling Zheng, Ling Jiang and Wen-Li Ma

    Citation: Cancer Cell International 2013 13:46

    Content type: Primary research

    Published on:

  13. MicroRNAs are small RNA molecules that negatively regulate gene expression by translational inhibition or mRNA cleavage. The discovery that abnormal expression of particular miRNAs contributes to human disease...

    Authors: Sanja Jurcevic, Björn Olsson and Karin Klinga-Levan

    Citation: Cancer Cell International 2013 13:45

    Content type: Primary research

    Published on:

  14. Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular events involved in the development and progression of EC remain unclear. This study aimed to explore epigenetic modification...

    Authors: Bi-Lan Li, Wen Lu, Cong Lu, Jun-jie Qu, Ting-ting Yang, Qin Yan and Xiao-ping Wan

    Citation: Cancer Cell International 2013 13:44

    Content type: Primary research

    Published on:

  15. We studied the role of caspase-2 in apoptosis induction by taxanes (paclitaxel, novel taxane SB-T-1216) in breast cancer cells using SK-BR-3 (nonfunctional p53, functional caspase-3) and MCF-7 (functional p53,...

    Authors: Michael Jelínek, Kamila Balušíková, Dana Kopperová, Vlasta Němcová-Fürstová, Jan Šrámek, Julie Fidlerová, Ilaria Zanardi, Iwao Ojima and Jan Kovář

    Citation: Cancer Cell International 2013 13:42

    Content type: Primary research

    Published on:

  16. Nowadays, we believe that cancer is a genetic disease. We focus on the genetic targets and epigenetic changes in a tumor. Remarkably, many crucial signal pathways in a malignant cell involve “stem-ness” genes....

    Authors: Shi-Ming Tu

    Citation: Cancer Cell International 2013 13:40

    Content type: Hypothesis

    Published on:

  17. The cancer stem cell (CSC) theory proposes that tumours arise from and are sustained by a subpopulation of cells with both cancer and stem cell properties. One of the key hallmarks of CSCs is the ability to gr...

    Authors: Jo-Anne de la Mare, Jason N Sterrenberg, Mugdha G Sukhthankar, Maynard T Chiwakata, Denzil R Beukes, Gregory L Blatch and Adrienne L Edkins

    Citation: Cancer Cell International 2013 13:39

    Content type: Primary research

    Published on:

  18. Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene. ErbB1 encodes epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, involved mainly in cell proliferat...

    Authors: Camila Lauand, Paula Rezende-Teixeira, Beatriz Araújo Cortez, Evandro Luís de Oliveira Niero and Gláucia Maria Machado-Santelli

    Citation: Cancer Cell International 2013 13:38

    Content type: Primary research

    Published on:

  19. To elucidate the characteristics of T-cell receptor (TCR) signal transduction in T-cells from acute myeloid leukemia (AML), the mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1), A20, NF-...

    Authors: Li Shi, Shaohua Chen, Yuhong Lu, Xu Wang, Ling Xu, Fan Zhang, Lijian Yang, Xiuli Wu, Bo Li and Yangqiu Li

    Citation: Cancer Cell International 2013 13:37

    Content type: Primary research

    Published on:

  20. Hypoxia inducible factor-1 α (HIF-1α) has been identified as an important novel target in apoptosis resistance of pediatric tumors such as Rhabdomyosarcoma (RMS) and Ewing’s sarcoma (ES). Evidence suggests tha...

    Authors: Mehtap Kilic-Eren, Tulin Boylu and Vedrana Tabor

    Citation: Cancer Cell International 2013 13:36

    Content type: Primary research

    Published on:

  21. T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive hematologic malignancy. Immune tolerance induced by CD4+CD25+ regulatory T cells (Tregs) with high expression of Foxp3 is an important hypothesis...

    Authors: Xiaodan Luo, Huo Tan, Yueqiao Zhou, Tiantian Xiao, Chunyan Wang and Yangqiu Li

    Citation: Cancer Cell International 2013 13:34

    Content type: Primary research

    Published on:

  22. Ovarian cancer constitutes nearly 4% of all cancers among women and is the leading cause of death from gynecologic malignancies in the Western world. Standard first line adjuvant chemotherapy treatments includ...

    Authors: Ilenia Pellicciotta, Chia-Ping Huang Yang, Charis A Venditti, Gary L Goldberg and Shohreh Shahabi

    Citation: Cancer Cell International 2013 13:33

    Content type: Primary research

    Published on:

  23. The use of imatinib, an ABL tyrosine kinase inhibitor, has led to a dramatic change in the management of BCR-ABL-positive leukemia patients. However, resistance to imatinib mediated by mutations in the BCR-ABL...

    Authors: Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Shinya Kimura, Taira Maekawa and Kazuma Ohyashiki

    Citation: Cancer Cell International 2013 13:32

    Content type: Primary research

    Published on:

  24. Liver cancer is one of the most frequent cancers in the world. Targeted therapy of cancer with specific inhibitors is developing and has shown promising antitumor efficacy. CCI-779 (temsirolimus), a specific i...

    Authors: Shuyu Li, Yan Liang, Manlin Wu, Xiaojing Wang, Haixia Fu, Yuhao Chen and Zhigang Wang

    Citation: Cancer Cell International 2013 13:30

    Content type: Primary research

    Published on:

  25. We have investigated the ability of Mifepristone, an anti-progestin and anti-glucocorticoid drug, to modulate the antitumor effect of current standard clinical treatment in glioblastoma xenografts.

    Authors: Monserrat Llaguno-Munive, Luis Alberto Medina, Rafael Jurado, Mario Romero-Piña and Patricia Garcia-Lopez

    Citation: Cancer Cell International 2013 13:29

    Content type: Primary research

    Published on:

  26. Macrophage migration inhibitory factor (MIF) is important in regulating cell proliferation and apoptosis in both normal and cancerous cells, and may be important in cancer progression and metastasis. In human ...

    Authors: Yubiao Guo, Junna Hou, Yifeng Luo and Dujuan Wang

    Citation: Cancer Cell International 2013 13:28

    Content type: Primary research

    Published on:

    The Erratum to this article has been published in Cancer Cell International 2013 13:84

  27. The editor and editorial board of Cancer Cell International would like to thank Angela Panther for her continued hard work throughout 2012 in keeping the journal going as our managing editor. We take this opportu...

    Authors: Denys Wheatley

    Citation: Cancer Cell International 2013 13:22

    Content type: Reviewer acknowledgement

    Published on:

  28. β-elemene, a natural sesquiterpene extracted from the essential oils of Curcuma aromatica Salisb, has been shown to be effective against a wide range of tumors. In this study, the antitumor effect of β-elemene on...

    Authors: Zhi-Jun Dai, Wei Tang, Wang-Feng Lu, Jie Gao, Hua-Feng Kang, Xiao-Bin Ma, Wei-Li Min, Xi-Jing Wang and Wen-Ying Wu

    Citation: Cancer Cell International 2013 13:27

    Content type: Primary research

    Published on:

  29. Beclin1 is a well-known key regulator of autophagy, which is also a haploinsufficient tumor suppressor. Current studies revealed that down-regulation or monoallelic deletions of Beclin1 were frequently found i...

    Authors: Xiaoshu Li, Jun Yan, Lisheng Wang, Fengjun Xiao, Yuefeng Yang, Xiaozhong Guo and Hua Wang

    Citation: Cancer Cell International 2013 13:26

    Content type: Primary research

    Published on:

  30. Arsenic Trioxide (ATO) has shown remarkable efficacy for the treatment of multiple myeloma (MM). However, the mechanism by which ATO exerts its inhibitory effect on the proliferation of myeloma cells remains t...

    Authors: Jiasheng Hu, Xiao Huang, Xiuli Hong, Quanyi Lu and Xiongpeng Zhu

    Citation: Cancer Cell International 2013 13:25

    Content type: Primary research

    Published on:

  31. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Although much is known about both the cellular changes that lead to HCC and the etiological agents responsible for the majority of HCC ca...

    Authors: Yan Zhao, Wang Jian, Wei Gao, Ya-Xin Zheng, Yong-Kun Wang, Zhu-Qing Zhou, Hui Zhang and Cong-Jun Wang

    Citation: Cancer Cell International 2013 13:23

    Content type: Primary research

    Published on:

  32. Diverse functions of microRNAs (miRNAs), including effects on tumorigenesis, proliferation, and differentiation, have been reported, and several miRNAs have also been demonstrated to play an important role in ...

    Authors: Keiichiro Iida, Jun-ichi Fukushi, Yoshihiro Matsumoto, Yoshinao Oda, Yusuke Takahashi, Toshifumi Fujiwara, Yuko Fujiwara-Okada, Mihoko Hatano, Akira Nabashima, Satoshi Kamura and Yukihide Iwamoto

    Citation: Cancer Cell International 2013 13:21

    Content type: Primary research

    Published on:

  33. Clear cell renal cell carcinoma (ccRCC) cell lines with distinct metastatic potential are essential to study the mechanism of ccRCC metastasis. However, none of them originated from Chinese.

    Authors: Xiaojie Tan, Songqin He, Yifang Han, Yongwei Yu, Jianru Xiao, Danfeng Xu, Guoping Wang, Yan Du, Wenjun Chang, Jianhua Yin, Tong Su, Jianguo Hou and Guangwen Cao

    Citation: Cancer Cell International 2013 13:20

    Content type: Primary research

    Published on:

  34. Malignant mesothelioma is an asbestos-related fatal disease with no effective cure. We studied whether a green tea polyphenol, epigallocathechin-3-gallate (EGCG), could induce cell death in five human mesothel...

    Authors: Motohiko Satoh, Yukitoshi Takemura, Hironobu Hamada, Yoshitaka Sekido and Shunichiro Kubota

    Citation: Cancer Cell International 2013 13:19

    Content type: Primary research

    Published on:

  35. The loss of tumor suppressor gene expression is involved in the carcinogenesis of gastric cancer (GC). Klotho is a recently identified tumor suppressor gene that epigenetically inactivated in gastric cancer. Howe...

    Authors: Biao Xie, Jianping Zhou, Guoshun Shu, Dong-cai Liu, Jiapeng Zhou, Jinhui Chen and Lianwen Yuan

    Citation: Cancer Cell International 2013 13:18

    Content type: Primary research

    Published on:

  36. A fribotic tumor microenvironment promotes progression of cancer. In this study, we utilize a reconstituted basement membrane mimics Matrigel based three-dimensional organotypic culture (rBM 3-D) to investigat...

    Authors: Hong T Nguyen, Yan Zhuang, Lichun Sun, Steven P Kantrow, Jay K Kolls, Zongbing You, Ying Zhuo and Bin Shan

    Citation: Cancer Cell International 2013 13:16

    Content type: Primary research

    Published on:

  37. Celecoxib is a selective cyclooxygenase (COX)-2 inhibitor that has been reported to reduce the risk of breast cancer. In our previous study, celecoxib induced apoptosis and caused cell cycle arrest at the G0/G...

    Authors: Ling Wang, Fubiao Kang, Jie Li, Jing Zhang and Baoen Shan

    Citation: Cancer Cell International 2013 13:14

    Content type: Primary research

    Published on:

  38. Natural products, including plants, microorganisms and marines, have been considered as valuable sources for anticancer drug discovery. Many Chinese herbs have been discovered to be potential sources of antitu...

    Authors: Shengjie Yang, Qi Zhao, Hongmei Xiang, Minjie Liu, Qiuyun Zhang, Wei Xue, Baoan Song and Song Yang

    Citation: Cancer Cell International 2013 13:12

    Content type: Primary research

    Published on:

  39. Geldanamycin (GA) can be considered a relatively new component with a promising mode of action against human malignancies. It specifically targets heat shock protein 90 (Hsp90) and interferes with its function...

    Authors: Panagiotis K Karkoulis, Dimitrios J Stravopodis, Eumorphia G Konstantakou and Gerassimos E Voutsinas

    Citation: Cancer Cell International 2013 13:11

    Content type: Primary research

    Published on:

  40. This study examined whether combining paclitaxel (taxol) with a novel epigenetic agent phenethyl isothiocyanate (PEITC) will yield a synergistic effect on inhibiting breast cancer cells. Two drug-resistant bre...

    Authors: Katherine Liu, Shundong Cang, Yuehua Ma and Jen Wei Chiao

    Citation: Cancer Cell International 2013 13:10

    Content type: Primary research

    Published on:

  41. Senescence in the population of cells is often described as a program of restricted proliferative capacity, which is manifested by broad morphological and biochemical changes including a metabolic shift toward...

    Authors: Anna Litwiniec, Lidia Gackowska, Anna Helmin-Basa, Agnieszka Żuryń and Alina Grzanka

    Citation: Cancer Cell International 2013 13:9

    Content type: Primary research

    Published on:

  42. Small cell lung cancer (SCLC) is a special kind of lung cancers, lymph or blood metastasis of SCLC usually occurs in early stage. Studies in breast and colon cancer showed over expression of SATB1 could promot...

    Authors: Bo Huang, Hongli Zhou, Xiaodong Wang and Zhiliang Liu

    Citation: Cancer Cell International 2013 13:8

    Content type: Primary research

    Published on:

Annual Journal Metrics

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here